|
REVLIMID CAPS 25 MG/CAP Χάρτινη συσκευασία x 21 (σε BLISTERS PCTFE/PVC/ALU) 21 (σε BLISTERS PCTFE/PVC/ALU)
|
ORAL
|
CAP
|
25MG/CAP
|
3.910,46 €
|
7.161,6000 / g
|
Bristol-Myers Squibb EEIG
|
|
REVLIMID CAPS 15 MG/CAP Χάρτινη συσκευασία x 21 (σε BLISTERS PCTFE/PVC/ALU) 21 (σε BLISTERS PCTFE/PVC/ALU)
|
ORAL
|
CAP
|
15MG/CAP
|
3.337,73 €
|
10.187,9048 / g
|
Bristol-Myers Squibb EEIG
|
|
REVLIMID CAPS 10 MG/CAP Χάρτινη συσκευασία x 21 (σε BLISTERS PCTFE/PVC/ALU) 21 (σε BLISTERS PCTFE/PVC/ALU)
|
ORAL
|
CAP
|
10MG/CAP
|
3.173,88 €
|
14.496,0476 / g
|
Bristol-Myers Squibb EEIG
|
|
REVLIMID CAPS 5MG/CAP Χάρτινη συσκευασία x 21 (σε BLISTERS PCTFE/PVC/ALU) 21 (σε BLISTERS PCTFE/PVC/ALU)
|
ORAL
|
CAP
|
5MG/CAP
|
3.247,11 €
|
29.661,1429 / g
|
Bristol-Myers Squibb EEIG
|
|
REVLIMID CAPS 20MG/CAP BT x21 (BLIST 3x7) σε BLISTERS (PVC/PCTFE/αλουμίνιο)
|
ORAL
|
CAP
|
20MG/CAP
|
4.225,03 €
|
9.672,1429 / g
|
Bristol-Myers Squibb EEIG
|
|
MYELOMIDE CAPS 5MG/CAP BTx21 καψάκια σε blisters 0PA/AL/PVC/AL
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
17.930,1905 / g
|
Αναβίωσις Ι.Κ.Ε.
|
|
MYELOMIDE CAPS 10MG/CAP BTx21 καψάκια σε blisters 0PA/AL/PVC/AL
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Αναβίωσις Ι.Κ.Ε.
|
|
MYELOMIDE CAPS 15MG/CAP BTx21 καψάκια σε blisters 0PA/AL/PVC/AL
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1270 / g
|
Αναβίωσις Ι.Κ.Ε.
|
|
MYELOMIDE CAPS 25MG/CAP BTx21 καψάκια σε blisters 0PA/AL/PVC/AL
|
ORAL
|
CAP
|
25MG/CAP
|
2.560,48 €
|
4.655,0476 / g
|
Αναβίωσις Ι.Κ.Ε.
|
|
CORTEDAL CAPS 5MG/CAP BTx21 caps [3 blist (PVC/ACLAR/AL)x7]
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
Demo Α.Β.Ε.Ε.
|
|
CORTEDAL CAPS 10MG/CAP BTx21 caps [3 blist (PVC/ACLAR/AL)x7]
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Demo Α.Β.Ε.Ε.
|
|
CORTEDAL CAPS 15MG/CAP BTx21 caps [3 blist (PVC/ACLAR/AL)x7]
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1270 / g
|
Demo Α.Β.Ε.Ε.
|
|
CORTEDAL CAPS 20MG/CAP BTx21 caps [3 blist (PVC/ACLAR/AL)x7]
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
6.286,9048 / g
|
Demo Α.Β.Ε.Ε.
|
|
CORTEDAL CAPS 25MG/CAP BTx21 caps [3 blist (PVC/ACLAR/AL)x7]
|
ORAL
|
CAP
|
25MG/CAP
|
2.560,48 €
|
4.655,0476 / g
|
Demo Α.Β.Ε.Ε.
|
|
LENALIDOMIDE/FARAN CAPS 5MG/CAP BTx21 caps (OPA/AL/PVC/AP blisters)
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
Faran Α.Β.Ε.Ε.
|
|
LENALIDOMIDE/FARAN CAPS 10MG/CAP BTx21 caps (OPA/AL/PVC/AP blisters)
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Faran Α.Β.Ε.Ε.
|
|
LENALIDOMIDE/FARAN CAPS 15MG/CAP BTx21 caps (OPA/AL/PVC/AP blisters)
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1270 / g
|
Faran Α.Β.Ε.Ε.
|
|
LENALIDOMIDE/FARAN CAPS 20MG/CAP BTx21 caps (OPA/AL/PVC/AP blisters)
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
6.286,9048 / g
|
Faran Α.Β.Ε.Ε.
|
|
LENALIDOMIDE/FARAN CAPS 25MG/CAP BTx21 caps (OPA/AL/PVC/AP blisters)
|
ORAL
|
CAP
|
25MG/CAP
|
2.560,48 €
|
4.655,0476 / g
|
Faran Α.Β.Ε.Ε.
|
|
LENALIDOMIDE ACCORD CAPS 5.0MG/CAP 21x1 καψάκια (μονάδα δόσης) σε BLISTERS OPA/alu/PVC/alu
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
Accord Healthcare S.L.U.
|
|
LENALIDOMIDE ACCORD CAPS 10.0MG/CAP 21x1 καψάκια (μονάδα δόσης) σε BLISTERS OPA/alu/PVC/alu
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Accord Healthcare S.L.U.
|
|
LENALIDOMIDE ACCORD CAPS 15.0MG/CAP 21x1 καψάκια (μονάδα δόσης) σε BLISTERS OPA/alu/PVC/alu
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1270 / g
|
Accord Healthcare S.L.U.
|
|
LENALIDOMIDE ACCORD CAPS 20.0MG/CAP 21x1 καψάκια (μονάδα δόσης) σε BLISTERS OPA/alu/PVC/alu
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
6.286,9048 / g
|
Accord Healthcare S.L.U.
|
|
LENALIDOMIDE ACCORD CAPS 25.0MG/CAP 21x1 καψάκια (μονάδα δόσης) σε BLISTERS OPA/alu/PVC/alu
|
ORAL
|
CAP
|
25MG/CAP
|
2.560,48 €
|
4.655,0476 / g
|
Accord Healthcare S.L.U.
|
|
LENALIDOMIDE/SANDOZ CAPS 5.0 MG/CAP BTx21 CAPS
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
Sandoz Pharmaceuticals d.d.
|
|
LENALIDOMIDE/SANDOZ CAPS 10.0 MG/CAP BTx21 CAPS
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Sandoz Pharmaceuticals d.d.
|
|
LENALIDOMIDE/SANDOZ CAPS 15.0 MG/CAP BTx21 CAPS
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1270 / g
|
Sandoz Pharmaceuticals d.d.
|
|
LENALIDOMIDE/SANDOZ CAPS 20.0 MG/CAP BTx21 CAPS
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
6.286,9048 / g
|
Sandoz Pharmaceuticals d.d.
|
|
LENALIDOMIDE/SANDOZ CAPS 25.0 MG/CAP BTx21 CAPS
|
ORAL
|
CAP
|
25MG/CAP
|
2.560,48 €
|
4.655,0476 / g
|
Sandoz Pharmaceuticals d.d.
|
|
LENALIDOMIDE KRKA CAPS 5MG/CAP 21 Χ 1 ΚΑΨΑΚΙΟ (ΜΟΝΑΔΑ ΔΟΣΗΣ) ΣΕ ΚΥΨΕΛΗ (OPA/AL/PVC-PET/AL)
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
Krka d.d.
|
|
LENALIDOMIDE KRKA CAPS 10MG/CAP 21 Χ 1 ΚΑΨΑΚΙΟ (ΜΟΝΑΔΑ ΔΟΣΗΣ) ΣΕ ΚΥΨΕΛΗ (OPA/AL/PVC-PET/AL)
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Krka d.d.
|
|
LENALIDOMIDE KRKA CAPS 15MG/CAP 21 Χ 1 ΚΑΨΑΚΙΟ (ΜΟΝΑΔΑ ΔΟΣΗΣ) ΣΕ ΚΥΨΕΛΗ (OPA/AL/PVC-PET/AL)
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1270 / g
|
Krka d.d.
|
|
LENALIDOMIDE KRKA CAPS 20MG/CAP 21 Χ 1 ΚΑΨΑΚΙΟ (ΜΟΝΑΔΑ ΔΟΣΗΣ) ΣΕ ΚΥΨΕΛΗ (OPA/AL/PVC-PET/AL)
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
6.286,9048 / g
|
Krka d.d.
|
|
LENALIDOMIDE KRKA CAPS 25MG/CAP 21 Χ 1 ΚΑΨΑΚΙΟ (ΜΟΝΑΔΑ ΔΟΣΗΣ) ΣΕ ΚΥΨΕΛΗ (OPA/AL/PVC-PET/AL)
|
ORAL
|
CAP
|
25MG/CAP
|
2.560,48 €
|
4.655,0476 / g
|
Krka d.d.
|
|
LENALIDOMIDE MYLAN CAPS 2.5MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
ORAL
|
CAP
|
2.5MG/CAP
|
1.088,86 €
|
19.279,8095 / g
|
Mylan Healthcare Ireland Ltd
|
|
LENALIDOMIDE MYLAN CAPS 5.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
Mylan Healthcare Ireland Ltd
|
|
LENALIDOMIDE MYLAN CAPS 7.5MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
ORAL
|
CAP
|
7.5MG/CAP
|
1.577,53 €
|
9.422,4127 / g
|
Mylan Healthcare Ireland Ltd
|
|
LENALIDOMIDE MYLAN CAPS 10.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Mylan Healthcare Ireland Ltd
|
|
LENALIDOMIDE MYLAN CAPS 15.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1270 / g
|
Mylan Healthcare Ireland Ltd
|
|
LENALIDOMIDE MYLAN CAPS 20.0MG/CAP BT x 21x1 καψάκια-μονάδα δόσης σε BLISTERS PVC/ACLAR αλουμίνιο
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
6.286,9048 / g
|
Mylan Healthcare Ireland Ltd
|
|
LENALIDOMIDE MYLAN CAPS 25.0MG/CAP BT x 21 x 1καψάκια - μονάδα δλοσης σε BLISTERS PVC/ACLAR/ αλουμίνιο
|
ORAL
|
CAP
|
25MG/CAP
|
2.560,48 €
|
4.655,0476 / g
|
Mylan Healthcare Ireland Ltd
|
|
LENALIDOMIDE/RAFARM CAPS 5MG/CAP BT X 21 CAPS (ΣΕ BLISTERS OPA/AL/PVC/AL)
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
Rafarm Α.Β.Ε.Ε.
|
|
LENALIDOMIDE/RAFARM CAPS 10MG/CAP BT X 21 CAPS (ΣΕ BLISTERS OPA/AL/PVC/AL)
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Rafarm Α.Β.Ε.Ε.
|
|
LENALIDOMIDE/RAFARM CAPS 15MG/CAP BT X 21 CAPS (ΣΕ BLISTERS OPA/AL/PVC/AL)
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1270 / g
|
Rafarm Α.Β.Ε.Ε.
|
|
LENALIDOMIDE/RAFARM CAPS 20MG/CAP BT X 21 CAPS (ΣΕ BLISTERS OPA/AL/PVC/AL)
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
6.286,9048 / g
|
Rafarm Α.Β.Ε.Ε.
|
|
LENALIDOMIDE/RAFARM CAPS 25MG/CAP BT X 21 CAPS (ΣΕ BLISTERS OPA/AL/PVC/AL)
|
ORAL
|
CAP
|
25MG/CAP
|
2.560,48 €
|
4.655,0476 / g
|
Rafarm Α.Β.Ε.Ε.
|
|
LENALIDOMIDE/GRINDEKS CAPS 5MG/CAP BT X 21 CAPS (ΣΕ BLISTERS AL/PVC/ACLAR/PVC)
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
Grindeks AS
|
|
LENALIDOMIDE/GRINDEKS CAPS 10MG/CAP BT X 21 CAPS (ΣΕ BLISTERS AL/PVC/ACLAR/PVC)
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Grindeks AS
|
|
LENALIDOMIDE/GRINDEKS CAPS 15MG/CAP BT X 21 CAPS (ΣΕ BLISTERS AL/PVC/ACLAR/PVC)
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1270 / g
|
Grindeks AS
|
|
LENALIDOMIDE/GRINDEKS CAPS 20MG/CAP BT X 21 CAPS (ΣΕ BLISTERS AL/PVC/ACLAR/PVC)
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
6.286,9048 / g
|
Grindeks AS
|
|
LENALIDOMIDE/GRINDEKS CAPS 25MG/CAP BT X 21 CAPS (ΣΕ BLISTERS AL/PVC/ACLAR/PVC)
|
ORAL
|
CAP
|
25MG/CAP
|
2.560,48 €
|
4.655,0476 / g
|
Grindeks AS
|
|
LENALIDOMIDE/PHARMAZAC CAPS 5MG/CAP BT X 21 CAPS (σε BLISTERS PVC/PCTFE/AL)
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
Pharmazac Α.Ε.
|
|
LENALIDOMIDE/PHARMAZAC CAPS 10MG/CAP BT X 21 CAPS (σε BLISTERS PVC/PCTFE/AL)
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Pharmazac Α.Ε.
|
|
LENALIDOMIDE/PHARMAZAC CAPS 15MG/CAP BT X 21 CAPS ( σε BLISTERS PVC/PCTFE/AL)
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1270 / g
|
Pharmazac Α.Ε.
|
|
LENALIDOMIDE/PHARMAZAC CAPS 20MG/CAP BT X 21 CAPS ( σε BLISTERS PVC/PCTFE/AL)
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
6.286,9048 / g
|
Pharmazac Α.Ε.
|
|
LENALIDOMIDE/PHARMAZAC CAPS 25MG/CAP BT X 21 CAPS ( σε BLISTERS PVC/PCTFE/AL)
|
ORAL
|
CAP
|
25MG/CAP
|
2.560,48 €
|
4.655,0476 / g
|
Pharmazac Α.Ε.
|
|
LENALIDOMIDE/ARITI CAPS 5MG/CAP BT X 21 CAPS (ΔΙΑΤΡΗΤΕΣ ΚΥΨΕΛΕΣ ΜΟΝΑΔΑΣ ΔΟΣΗΣ/PVC/PCTFE/AL)
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
Ariti Α.Ε.
|
|
LENALIDOMIDE/ARITI CAPS 10MG/CAP BT X 21 CAPS (ΔΙΑΤΡΗΤΕΣ ΚΥΨΕΛΕΣ ΜΟΝΑΔΑΣ ΔΟΣΗΣ/PVC/PCTFE/AL)
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Ariti Α.Ε.
|
|
LENALIDOMIDE/ARITI CAPS 15MG/CAP BT X 21 CAPS (ΔΙΑΤΡΗΤΕΣ ΚΥΨΕΛΕΣ ΜΟΝΑΔΑΣ ΔΟΣΗΣ/PVC/PCTFE/AL)
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1270 / g
|
Ariti Α.Ε.
|
|
LENALIDOMIDE/ARITI CAPS 20MG/CAP BT X 21 CAPS (ΔΙΑΤΡΗΤΕΣ ΚΥΨΕΛΕΣ ΜΟΝΑΔΑΣ ΔΟΣΗΣ/PVC/PCTFE/AL)
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
6.286,9048 / g
|
Ariti Α.Ε.
|
|
LENALIDOMIDE/ARITI CAPS 25MG/CAP BT X 21 CAPS (ΔΙΑΤΡΗΤΕΣ ΚΥΨΕΛΕΣ ΜΟΝΑΔΑΣ ΔΟΣΗΣ/PVC/PCTFE/AL)
|
ORAL
|
CAP
|
25MG/CAP
|
2.746,51 €
|
4.655,0476 / g
|
Ariti Α.Ε.
|
|
LENALIDOMIDE/STADA CAPS 5MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
STADA Arzneimittel AG
|
|
LENALIDOMIDE/STADA CAPS 10MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
STADA Arzneimittel AG
|
|
LENALIDOMIDE/STADA CAPS 15MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1270 / g
|
STADA Arzneimittel AG
|
|
LENALIDOMIDE/STADA CAPS 20MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
6.286,9048 / g
|
STADA Arzneimittel AG
|
|
LENALIDOMIDE/STADA CAPS 25MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
ORAL
|
CAP
|
25MG/CAP
|
2.746,51 €
|
4.655,0476 / g
|
STADA Arzneimittel AG
|
|
LENALIDOMIDE/TEVA CAPS 5MG/CAP BT X 21 CAPS ΣΕ BLISTER OPA/ALU/PVC/ALU
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
Teva B.V.
|
|
LENALIDOMIDE/TEVA CAPS 10MG/CAP BT X 21 CAPS ΣΕ BLISTER OPA/ALU/PVC/ALU
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Teva B.V.
|
|
LENALIDOMIDE/TEVA CAPS 15MG/CAP BT X 21 CAPS ΣΕ BLISTER OPA/ALU/PVC/ALU
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1270 / g
|
Teva B.V.
|
|
LENALIDOMIDE/TEVA CAPS 20MG/CAP BT X 21 CAPS ΣΕ BLISTER OPA/ALU/PVC/ALU
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
6.286,9048 / g
|
Teva B.V.
|
|
LENALIDOMIDE/TEVA CAPS 25MG/CAP BT X 21 CAPS ΣΕ BLISTER OPA/ALU/PVC/ALU
|
ORAL
|
CAP
|
25MG/CAP
|
2.746,51 €
|
4.655,0476 / g
|
Teva B.V.
|
|
LENALIDOMIDE/COOPER CAPS 5MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
Cooper Α.Ε.
|
|
LENALIDOMIDE/COOPER CAPS 10MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Cooper Α.Ε.
|
|
LENALIDOMIDE/COOPER CAPS 15MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1587 / g
|
Cooper Α.Ε.
|
|
LENALIDOMIDE/COOPER CAPS 20MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
6.286,9048 / g
|
Cooper Α.Ε.
|
|
LENALIDOMIDE/COOPER CAPS 25MG/CAP BT X 21 CAPS ΣΕ BLISTER PVC/PCTFE/AL
|
ORAL
|
CAP
|
25MG/CAP
|
2.746,51 €
|
4.655,0476 / g
|
Cooper Α.Ε.
|
|
LENALIDOMIDE/ABBIO CAPS 5MG/CAP BT X 21 CAPS (σε BLISTERS PVC/PCTFE/AL)
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
|
Abbio Therapeutics Μ.Ι.Κ.Ε.
|
|
LENALIDOMIDE/ABBIO CAPS 10MG/CAP BT X 21 CAPS (σε BLISTERS PVC/PCTFE/AL)
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
|
Abbio Therapeutics Μ.Ι.Κ.Ε.
|
|
LENALIDOMIDE/ABBIO CAPS 15MG/CAP BT X 21 CAPS ( σε BLISTERS PVC/PCTFE/AL)
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
|
Abbio Therapeutics Μ.Ι.Κ.Ε.
|
|
LENALIDOMIDE/ABBIO CAPS 20MG/CAP BT X 21 CAPS ( σε BLISTERS PVC/PCTFE/AL)
|
ORAL
|
CAP
|
20MG/CAP
|
2.759,74 €
|
|
Abbio Therapeutics Μ.Ι.Κ.Ε.
|
|
LENALIDOMIDE/ABBIO CAPS 25MG/CAP BT X 21 CAPS ( σε BLISTERS PVC/PCTFE/AL)
|
ORAL
|
CAP
|
25MG/CAP
|
2.560,48 €
|
|
Abbio Therapeutics Μ.Ι.Κ.Ε.
|
|
RENALYD CAPS 5MG/CAP BT X 21 CAPS (BLISTERS OPA/ALU/PVC/ALU)
|
ORAL
|
CAP
|
5MG/CAP
|
2.131,27 €
|
19.279,7143 / g
|
Innovis Health Α.Ε.
|
|
RENALYD CAPS 10MG/CAP BT X 21 CAPS (BLISTERS OPA/ALU/PVC/ALU)
|
ORAL
|
CAP
|
10MG/CAP
|
2.083,20 €
|
9.422,4286 / g
|
Innovis Health Α.Ε.
|
|
RENALYD CAPS 15MG/CAP BT X 21 CAPS (BLISTERS OPA/ALU/PVC/ALU)
|
ORAL
|
CAP
|
15MG/CAP
|
2.190,80 €
|
6.622,1587 / g
|
Innovis Health Α.Ε.
|
|
RENALYD CAPS 25MG/CAP BT X 21 CAPS (BLISTERS OPA/ALU/PVC/ALU)
|
ORAL
|
CAP
|
25MG/CAP
|
2.746,51 €
|
4.655,0476 / g
|
Innovis Health Α.Ε.
|